These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4115367)

  • 1. Toxic epidermal necrolysis.
    Ammann AJ; Tooley WH; Hong R
    Lancet; 1972 Sep; 2(7775):484-5. PubMed ID: 4115367
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-host reaction and toxic epidermal necrolysis.
    Peck GL; Elias PM; Graw RG
    Lancet; 1972 Nov; 2(7787):1151-3. PubMed ID: 4117232
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced toxic epidermal necrolysis.
    Heng MC
    Br J Dermatol; 1985 Nov; 113(5):597-600. PubMed ID: 4063192
    [No Abstract]   [Full Text] [Related]  

  • 4. Clues to pathogenesis of toxic epidermal necrolysis.
    Merot Y; Saurat JH
    Int J Dermatol; 1985 Apr; 24(3):165-8. PubMed ID: 3888879
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic epidermal necrolysis from graft-vs-host disease. Occurrence in a patient with thymic hypoplasia.
    McCarty JR; Raimer SS; Jarratt M
    Am J Dis Child; 1978 Mar; 132(3):282-4. PubMed ID: 24335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-dependent binding of circulating antibodies in drug-induced toxic epidermal necrolysis.
    Hensen EJ; Claas FH; Vermeer BJ
    Lancet; 1981 Jul; 2(8238):151-2. PubMed ID: 6113511
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction.
    Paquet P; Arrese JE; Beguin Y; Piérard GE
    Curr Top Pathol; 2001; 94():49-63. PubMed ID: 11443887
    [No Abstract]   [Full Text] [Related]  

  • 9. Graft-versus-host disease and toxic epidermal necrolysis.
    Krueger GR
    Lancet; 1973 Feb; 1(7797):268-9. PubMed ID: 4119418
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of basal cell immunofluorescence in drug-induced toxic epidermal necrolysis.
    Stein KM; Schlappner OL; Heaton CL; Decherd JW
    Br J Dermatol; 1972 Mar; 86(3):246-52. PubMed ID: 4553158
    [No Abstract]   [Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Eginli A; Shah K; Watkins C; Krishnaswamy G
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):143-147. PubMed ID: 28153080
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases.
    Villada G; Roujeau JC; Cordonnier C; Bagot M; Kuentz M; Wechsler J; Vernant JP
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):870-5. PubMed ID: 2254472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that 'toxic' epidermal necrolysis can be 'non-toxic'.
    Dumas M; Hua C; Hotz C; Velter C; Duong TA; Maraffi T; Ortonne N; Hüe S; Fardet L; de Prost N; Wolkenstein P; Ingen-Housz-Oro S; Chosidow O
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):e360-e361. PubMed ID: 29524279
    [No Abstract]   [Full Text] [Related]  

  • 17. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis-like graft vs host disease following orthotopic liver transplantation: a case with skin chimerism.
    López-Valle A; García-Reyne A; Loinaz-Segurola C; Sanchez-Pina J; Rodríguez-Peralto JL; Zarco-Olivo C
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e663-e665. PubMed ID: 34014572
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxic epidermal necrolysis after excretory pyelography. Immunologic-mediated contrast medium reaction?
    Kaftori JK; Abraham Z; Gilhar A
    Int J Dermatol; 1988 Jun; 27(5):346-7. PubMed ID: 3391731
    [No Abstract]   [Full Text] [Related]  

  • 20. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Induced by Fexofenadine.
    Teo SL; Santosa A; Bigliardi PL
    J Investig Allergol Clin Immunol; 2017 Jun; 27(3):191-193. PubMed ID: 28570227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.